Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Cancer Research Communications
|
December 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination
Kristen Simmons, Jane V Thomas, Kaysia Ludford, et al.
ESMO Open
|
September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
E E Dumbrava, S G Call, H J Huang, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction
F Janku, H J Huang, T Fujii, et al.
Oncotarget
|
May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
Filip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Oncotarget
|
September 26, 2015
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
Filip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Cancer Research Communications
|
November 16, 2022
Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer
Van K Morris, Michael J Overman, Michael Lam, et al.
Molecular Cancer Therapeutics
|
May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System
Filip Janku, Helen J Huang, Bart Claes, et al.
Cancer Cell
|
August 29, 2025
Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAF<sup>V600E</sup> metastatic colorectal cancer
Van K Morris, Christine M Parseghian, Vahid Bahrambeigi, et al.
JNCI Cancer Spectrum
|
May 11, 2024
Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume
Enoch Chang, Franklin C L Wong, Beth A Chasen, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Cancer Research Communications
|
December 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination
Kristen Simmons, Jane V Thomas, Kaysia Ludford, et al.
ESMO Open
|
September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
E E Dumbrava, S G Call, H J Huang, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction
F Janku, H J Huang, T Fujii, et al.
Oncotarget
|
May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
Filip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Oncotarget
|
September 26, 2015
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
Filip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Cancer Research Communications
|
November 16, 2022
Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer
Van K Morris, Michael J Overman, Michael Lam, et al.
Molecular Cancer Therapeutics
|
May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System
Filip Janku, Helen J Huang, Bart Claes, et al.
Cancer Cell
|
August 29, 2025
Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAF<sup>V600E</sup> metastatic colorectal cancer
Van K Morris, Christine M Parseghian, Vahid Bahrambeigi, et al.
JNCI Cancer Spectrum
|
May 11, 2024
Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume
Enoch Chang, Franklin C L Wong, Beth A Chasen, et al.
Page
of 6